Skip to main content
Erschienen in: Journal of Cancer Education 1/2018

16.04.2016

Feasibility Test of a Community-Relevant Intervention Designed to Promote African American Participation in Translational, Breast Cancer Disparities Research: Know About Health Options for Women (Know HOW)

verfasst von: Karen Hye-cheon Kim Yeary, Page Moore, Jerome Turner, Leah Dawson, Seongkum Heo, Paul Greene

Erschienen in: Journal of Cancer Education | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

There are marked racial differences in breast cancer, the second leading cause of death among US women. Understanding the causes of these differences is essential to eliminate breast cancer inequities. More prevalent in African American than in Caucasian women, metabolic syndrome has been associated with breast cancer outcomes. Further research is needed to understand metabolic syndrome’s role in breast cancer disparities, thus novel strategies to increase minority participation in research are important. We embedded two approaches (comprehensive, focused) to increase African American participation in breast cancer research in a state-wide service program and pilot tested both approaches in rural African American women. We conducted three comprehensive and three focused outreach programs (n = 48) and assessed research participation through consent and actual provision of data for four types of data: survey, anthropometric, blood, and mammography records. The majority of participants provided written consent for all data collection procedures (96 % survey; 92 % anthropometric; 94 %, blood; 100 % mammography). There were no between group differences in consent rates. There was variation in the overall proportion of participants who provided data (96 % survey; 92 % anthropometric; 73 % blood; 40 % mammography). Women in the comprehensive approach were less likely to return for a scheduled mammogram than women in the focused approach (19 % vs 64 %, p = 0.0236). Both outreach programs promoted African American engagement in research. Differences in the provision of data by type may have been due to participant burden (i.e., time required to provide data). Study designs that embed research in service programs have promise to increase minority research participation.
Literatur
1.
Zurück zum Zitat Society AC (2006) Cancer facts and figures 2006 Society AC (2006) Cancer facts and figures 2006
2.
Zurück zum Zitat Lannin DR et al (2002) Impacting cultural attitudes in African-American women to decrease breast cancer mortality. Am J Surg 184(5):418–423CrossRefPubMed Lannin DR et al (2002) Impacting cultural attitudes in African-American women to decrease breast cancer mortality. Am J Surg 184(5):418–423CrossRefPubMed
3.
Zurück zum Zitat Ward E et al (2004) Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 54(2):78–93CrossRefPubMed Ward E et al (2004) Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 54(2):78–93CrossRefPubMed
4.
Zurück zum Zitat Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287(3):356–359CrossRefPubMed Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287(3):356–359CrossRefPubMed
5.
Zurück zum Zitat Caballero A (2003) Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease. Obes Res 11(11):1278–1289CrossRefPubMed Caballero A (2003) Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease. Obes Res 11(11):1278–1289CrossRefPubMed
6.
Zurück zum Zitat Shavers VL, Brown ML (2002) Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 94(5):334–357CrossRefPubMed Shavers VL, Brown ML (2002) Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 94(5):334–357CrossRefPubMed
7.
Zurück zum Zitat Xue F, Michels KB (2007) Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr 86(3):s823–s835PubMed Xue F, Michels KB (2007) Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr 86(3):s823–s835PubMed
8.
Zurück zum Zitat Rose DP, Haffner SM, Baillargeon J (2007) Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women. Endocr Rev 28(7):763–777CrossRefPubMed Rose DP, Haffner SM, Baillargeon J (2007) Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women. Endocr Rev 28(7):763–777CrossRefPubMed
9.
Zurück zum Zitat Kabat GC et al (2009) A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer. Cancer Epidemiol Biomark Prev 18(7):2046–2053CrossRef Kabat GC et al (2009) A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer. Cancer Epidemiol Biomark Prev 18(7):2046–2053CrossRef
10.
Zurück zum Zitat Bjorge T et al (2010) Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project. Cancer Epidemiol Biomark Prev 19(7):1737–1745CrossRef Bjorge T et al (2010) Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project. Cancer Epidemiol Biomark Prev 19(7):1737–1745CrossRef
11.
Zurück zum Zitat Ford JG et al (2008) Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 112(2):228–242CrossRefPubMed Ford JG et al (2008) Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 112(2):228–242CrossRefPubMed
12.
Zurück zum Zitat Movsas B et al (2007) Who enrolls onto clinical oncology trials? A radiation Patterns Of Care Study analysis. Int J Radiat Oncol Biol Phys 68(4):1145–1150CrossRefPubMed Movsas B et al (2007) Who enrolls onto clinical oncology trials? A radiation Patterns Of Care Study analysis. Int J Radiat Oncol Biol Phys 68(4):1145–1150CrossRefPubMed
13.
Zurück zum Zitat Ford BM et al (2006) Factors associated with enrollment in cancer genetics research. Cancer Epidemiol Biomark Prev 15(7):1355–1359CrossRef Ford BM et al (2006) Factors associated with enrollment in cancer genetics research. Cancer Epidemiol Biomark Prev 15(7):1355–1359CrossRef
14.
Zurück zum Zitat Gotay CC, Wilson ME (1998) Social support and cancer screening in African American, Hispanic, and Native American women. Cancer Pract 6(1):31–37CrossRefPubMed Gotay CC, Wilson ME (1998) Social support and cancer screening in African American, Hispanic, and Native American women. Cancer Pract 6(1):31–37CrossRefPubMed
15.
Zurück zum Zitat Viswanathan M et al (2004) Community-based participatory research: assessing the evidence. Evidence Report/Technology Assessment (Summary) (99):1–8 Viswanathan M et al (2004) Community-based participatory research: assessing the evidence. Evidence Report/Technology Assessment (Summary) (99):1–8
16.
Zurück zum Zitat Will JC et al (2002) Health promotion interventions for disadvantaged women: overview of the WISEWOMAN projects. J Women’s Health 2004. 13(5):484–502 Will JC et al (2002) Health promotion interventions for disadvantaged women: overview of the WISEWOMAN projects. J Women’s Health 2004. 13(5):484–502
17.
Zurück zum Zitat Alexy BB, Elnitsky C (1998) Rural mobile health unit: outcomes. Public health nursing (Boston Mass) 15(1):3–11CrossRef Alexy BB, Elnitsky C (1998) Rural mobile health unit: outcomes. Public health nursing (Boston Mass) 15(1):3–11CrossRef
18.
Zurück zum Zitat Harrison G ed (1997) Lower Mississippi Delta Nutrition Intervention Research Consortium. Nutrition and health Status in the Lower Mississippi Delta of Arkansas, Louisiana, Mississippi: A Review of Existing Data. Westat Inc: Rockville, MD Harrison G ed (1997) Lower Mississippi Delta Nutrition Intervention Research Consortium. Nutrition and health Status in the Lower Mississippi Delta of Arkansas, Louisiana, Mississippi: A Review of Existing Data. Westat Inc: Rockville, MD
19.
20.
Zurück zum Zitat Resnicow K et al (1999) Cultural sensitivity in public health: defined and demystified. Ethn Dis 9(1):10–21PubMed Resnicow K et al (1999) Cultural sensitivity in public health: defined and demystified. Ethn Dis 9(1):10–21PubMed
21.
Zurück zum Zitat Erwin DO et al (2003) Replication and dissemination of a cancer education model for African American women. Cancer Control 10(5 Suppl):13–21CrossRefPubMed Erwin DO et al (2003) Replication and dissemination of a cancer education model for African American women. Cancer Control 10(5 Suppl):13–21CrossRefPubMed
22.
Zurück zum Zitat Nelson DE et al (2004) The Health Information National Trends Survey (HINTS): development, design, and dissemination. J Health Commun 9(5):443–460, discussion 81-4CrossRefPubMed Nelson DE et al (2004) The Health Information National Trends Survey (HINTS): development, design, and dissemination. J Health Commun 9(5):443–460, discussion 81-4CrossRefPubMed
23.
Zurück zum Zitat Prevention C.f.D.C.a (2010) Behavioral Risk Factor Surveillance System Survey Data. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2010: Atlanta, Georgia Prevention C.f.D.C.a (2010) Behavioral Risk Factor Surveillance System Survey Data. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2010: Atlanta, Georgia
Metadaten
Titel
Feasibility Test of a Community-Relevant Intervention Designed to Promote African American Participation in Translational, Breast Cancer Disparities Research: Know About Health Options for Women (Know HOW)
verfasst von
Karen Hye-cheon Kim Yeary
Page Moore
Jerome Turner
Leah Dawson
Seongkum Heo
Paul Greene
Publikationsdatum
16.04.2016
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 1/2018
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-016-1032-3

Weitere Artikel der Ausgabe 1/2018

Journal of Cancer Education 1/2018 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.